Word

SANGUINE

Status

Pending

Status Code

647

Status Date

Tuesday, September 3, 2024

Serial Number

98097064

Mark Type

3

Filing Date

Friday, July 21, 2023

Trademark Owner History

Sanguine Biosciences, Inc.

Classifications

42 Research laboratory analysis of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Research laboratory services providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Providing an online searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes; Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research; Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications

The mark consists of the stylized wording "SANGUINE" wherein the dot over the letter "i" is a droplet.
Color is not claimed as a feature of the mark.

Trademark Events

Jul 25, 2023

New Application Entered

Jun 12, 2024

Correspondence Received In Law Office

Aug 21, 2023

New Application Office Supplied Data Entered

Aug 22, 2023

Notice Of Design Search Code E-Mailed

Mar 25, 2024

Assigned To Examiner

Mar 25, 2024

Non-Final Action Written

Mar 25, 2024

Non-Final Action E-Mailed

Mar 25, 2024

Notification Of Non-Final Action E-Mailed

Jun 12, 2024

Teas Response To Office Action Received

Jun 12, 2024

Teas/Email Correspondence Entered

Jul 2, 2024

Notification Of Final Refusal Emailed

Jul 2, 2024

Final Refusal Written

Jul 2, 2024

Removed From Teas Plus

Jul 2, 2024

Restore To Teas Plus

Jul 2, 2024

Final Refusal E-Mailed

Aug 29, 2024

Correspondence Received In Law Office

Aug 29, 2024

Teas/Email Correspondence Entered

Aug 29, 2024

Teas Request For Reconsideration Received

Sep 3, 2024

Notification Of Examiners Amendment E-Mailed

Sep 3, 2024

Examiners Amendment -Written

Sep 3, 2024

Examiners Amendment E-Mailed

Sep 3, 2024

Examiner's Amendment Entered